Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis
Clinical trial NCT05374785 · COMPLETED
Trial details
- NCT number
- NCT05374785
- Sponsor
- Celon Pharma SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2024-05-27
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.